Explore our resources by research/diagnostic specialty or content type

ALPCO specialists are leveraging their extensive expertise to create a growing collection of resources for your research and testing. Find resources that benefit your work using the handy filters.

 Total Proinsulin Chemiluminescence ELISA
March 20, 2024

Product Data: Total Proinsulin Chemiluminescence ELISA

ALPCO’s Total Proinsulin Chemiluminescence ELISA offers excellent sensitivity and the greatest dynamic range on the 
market. 

GLP-1 Amide Elisa
March 20, 2024

Product Data: Active GLP-1 (7-36) amide Chemiluminescence ELISA

ALPCO’s Active GLP-1 (7-36) amide Chemiluminescence ELISA accurately measures the major biologically active circulating form of GLP-1.1,2 This well-characterized assay provides high analytical sensitivity, a short incubation time, and measures active GLP-1 (7-36) amide in fasted and fed samples.

Rodent Insulin Chemiluminescence ELISA
March 20, 2024

Product Data: Rodent Insulin Chemiluminescence ELISA

The STELLUX® Rodent Insulin ELISA provides the flexibility to run both mouse and rat samples on the same plate with minimal to no dilution and a short two hour incubation.

Insulin Chemiluminescence ELISA
March 19, 2024

Product Data: Insulin Chemiluminescence ELISA

ALPCO’s Insulin Chemiluminescence ELISA detects insulin at levels as low as 20 pg/mL in human serum, plasma, and β-islet tissue culture supernatants, without cross-reactivity to human intact proinsulin, mouse insulin, or rat insulin.

GLP-1 Amide Elisa
March 18, 2024

Product Data Package: Active GLP-1 (7-36) amide ELISA

ALPCO's STELLUX® Chemi Active GLP-1 (7-36) Amide ELISA provides accurate quantification and resolves sample size and analytical performance issues.

Biomarker Monitoring for the Management of Crohn’s Disease
February 7, 2024

[Infographic] Biomarker Monitoring for the Management of Crohn’s Disease

This infographic distills the essence of the new American Gastroenterological Association (AGA) Clinical Practice Guideline on the Role of Biomarkers in Crohn's Disease (CD). It sheds light on the nuanced recommendations for using biomarkers to monitor and evaluate CD, emphasizing their value in conjunction with clinical symptoms. 

8 Questions to Ask Before Choosing an Allergy Testing Platform
November 21, 2023

Celebrating Diabetes Research

In honor of scientists and researchers in the field of diabetes, we've compiled a partial list of their 2023 published work. These publications aren't just studies; they're milestones on the path to a healthier future, made possible by their dedication. 

What makes this list so special to ALPCO? It's a testament to how our products empower these tireless champions in their quest for discoveries and breakthroughs in diabetes research. 

8 Questions to Ask Before Choosing an Allergy Testing Platform
November 17, 2023

8 Questions to Ask Before Choosing an Allergy Testing Platform

1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50+ unique molecular allergens. Because molecular allergens can be precisely replicated with very high purity, th...
Calprotectin Test Differentiates IBD from IBS
October 23, 2023

Differentiating IBD from IBS with Fecal Calprotectin Testing

In an effort to improve patient care, an increasing number of gastroenterologists are using fecal calprotectin levels as a first step in the diagnosis of IBD versus IBS. ALPCO tests enable clinicians to accurately assess patients via calprotectin and quickly start patients on the right treatment path.

AutoPlex Automated Multiplex Biomarker Analysis
September 25, 2023

AutoPlex Automated Multiplex Biomarker Analysis

ALPCO’s automated multiplex assay, AutoPlex GI Panel, provides sensitive and accurate measurement of up to 5 GI biomarkers in human stool samples. The panel combines the workflow advantages of multiplexing with the proven reliability of traditional chemiluminescence sandwich immunoassays to enable batched sample processing for related biomarkers.